Today: 10 June 2026
Browse Category

NASDAQ:CCXI 24 December 2025 - 15 May 2026

Infleqtion Stock Jumps as Quantum Computing Firm Posts Record Q1 Revenue and Raises 2026 Outlook

Infleqtion Stock Jumps as Quantum Computing Firm Posts Record Q1 Revenue and Raises 2026 Outlook

Infleqtion reported first-quarter revenue of $9.5 million, up 14%, and raised its 2026 revenue outlook to at least $40 million. The company posted a GAAP operating loss of $33.6 million and ended March with $569 million in cash and equivalents. Shares rose about 5% Thursday, tracking gains in other quantum firms. Infleqtion recently launched Quantum Spectrum, an atom-based radio frequency sensing platform.
15 May 2026
···
Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (NASDAQ: CCCX) surged nearly 10% to $17.27 on Dec. 23, 2025, and traded above $18 pre-market after Infleqtion’s chief scientist won the John Stewart Bell Prize. The rally is linked to renewed momentum around CCCX’s planned merger with Infleqtion, a quantum technology firm. CCCX remains a SPAC, with trading driven by sentiment and headlines.
24 December 2025
···

Stock Market Today

  • U.S. Stock Futures Fall Amid Iran Strikes and Inflation Concerns
    June 10, 2026, 9:04 AM EDT. Nasdaq futures declined over 1% as former President Donald Trump warned of further actions against Iran following recent strikes. Investors also braced for upcoming Consumer Price Index (CPI) data, with economists forecasting inflation to surpass a critical threshold. The developments heightened market jitters, impacting investor sentiment ahead of key economic releases.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Go toTop